Literature DB >> 15869906

Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathy.

P Lindqvist1, B O Olofsson, C Backman, O Suhr, A Waldenström.   

Abstract

BACKGROUND: Familial amyloidotic polyneuropathy (FAP) is a hereditary systemic amyloidosis with cardiac involvement. As early identification of the cardiac involvement is of major clinical interest we performed this study to test the hypothesis that tissue Doppler imaging (TDI) and strain imaging (SI) might disclose cardiac involvement in patients with early stages of FAP.
METHODS: Twenty-two patients with FAP and 36 healthy controls were studied. Standard M-mode and Doppler echocardiography were performed. TDI and SI were used to assess the regional longitudinal left ventricular (LV) lateral and septal and right ventricular (RV) wall functions. All time intervals were corrected for heart rate by dividing with R-R interval and presented as percentage.
RESULTS: We found that patients in comparison with controls had increased LV and RV wall thickness and by using TDI a prolonged isovolumic relaxation time (IVRt) at the septal segment (15.0+/-7.0 vs 10.7+/-4.1%, p<0.05) and prolonged isovolumic contraction time (IVCt) at LV lateral (12.8+/-4.3 vs 10.1+/-3.3%, p<0.05), septal (12.5+/-3.5 vs 8.9+/-1.9%, p<0.001) and RV free wall segments (12.0+/-3.6 vs 8.3+/-2.1%, p<0.001). Strain was reduced at LV lateral basal segment (-4.6+/-14.0 vs -20.2+9.1, p<0.001), RV free wall mid segment (-16.2+/-12.8 vs -29.4+/-15.2) as well as both septal segments (-4.1+/-11.7 vs -16.2+/-9.0%, p<0.001, -8.8+/-11.5 vs -19.4+/-8.4%, p<0.001 for septal basal and mid-segment). Even in the absence of septal hypertrophy the septal strain was reduced and the regional IVCt was prolonged.
CONCLUSIONS: This is the first clinical study using TDI and strain in patients with FAP showing functional abnormalities before any morphological echocardiographic abnormalities were present. Both the left and right heart functions are involved and the disease should therefore be regarded as biventricular.

Entities:  

Mesh:

Year:  2006        PMID: 15869906     DOI: 10.1016/j.euje.2005.03.004

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  9 in total

Review 1.  Echocardiographic evaluation of cardiac amyloid.

Authors:  Wendy Tsang; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

Review 2.  Use of tissue Doppler imaging to identify and manage systemic diseases.

Authors:  Frank Weidemann; Joerg M Strotmann
Journal:  Clin Res Cardiol       Date:  2007-08-29       Impact factor: 5.460

Review 3.  Strain and strain rate deformation parameters: from tissue Doppler to 2D speckle tracking.

Authors:  Harry Pavlopoulos; Petros Nihoyannopoulos
Journal:  Int J Cardiovasc Imaging       Date:  2007-12-12       Impact factor: 2.357

4.  Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.

Authors:  Thomas Rudolph; Martin Wilhelm Kurz; Elisabeth Farbu
Journal:  Clin Med Res       Date:  2008-07-07

5.  Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.

Authors:  Adam Castaño; Daniel K Manson; Mathew S Maurer; Sabahat Bokhari
Journal:  Curr Cardiovasc Risk Rep       Date:  2017-04-25

Review 6.  Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.

Authors:  James A White; Nowell M Fine
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

Review 7.  Advanced echocardiographic techniques.

Authors:  Rebecca Perry; Majo Joseph
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

Review 8.  Evolving landscape in the management of transthyretin amyloidosis.

Authors:  Philip N Hawkins; Yukio Ando; Angela Dispenzeri; Alejandra Gonzalez-Duarte; David Adams; Ole B Suhr
Journal:  Ann Med       Date:  2015-11-27       Impact factor: 4.709

9.  Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients.

Authors:  Niklas Wange; Intissar Anan; Bo-Göran Ericzon; Johanna Pennlert; Björn Pilebro; Ole B Suhr; Jonas Wixner
Journal:  Transplantation       Date:  2018-02       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.